Do Probiotics Prevent C. Diff in Lyme Disease?
Antibiotics may increase C. diff risk
Probiotics may lower gastrointestinal complications
Balancing treatment risks and benefits remains important
There are at least 300,000 new cases of Lyme disease every year in the United States. As this patient group requires antibiotic therapy to treat Lyme disease and other tick-borne illnesses, there is a chance they can develop C. difficile. However, a rushed decision to avoid prescribing antibiotics—or discontinue them too soon—can also endanger the patient.
Doctors should carefully weigh the risk of acquiring Clostridium difficile-associated diarrhea (CDAD) against the risk of developing chronic complications from Lyme disease if an appropriate course of treatment is not provided.
Many patients ask, “Do probiotics prevent C. diff when taking antibiotics?” especially when treatment for Lyme disease requires longer antibiotic courses.
Published reports indicate antibiotic therapy for Lyme disease can lead to CDAD. One death associated with C. difficile in a Lyme disease patient has been reported. [1-3]
This balance becomes more difficult because undertreated Lyme disease may also lead to long-term neurologic and systemic complications, including persistent Lyme symptoms, chronic neurologic Lyme disease, autonomic dysfunction, and neuropsychiatric Lyme disease.
Do Probiotics Prevent C. Diff When Taking Antibiotics?
Several studies have evaluated whether probiotics prevent C. diff during antibiotic treatment, though questions remain regarding the best strains, timing, and dosing strategies.
Many patients search for probiotics for C diff prevention when prolonged antibiotic treatment is necessary.
The relationship between probiotics and C diff infection remains an active area of research, particularly for patients receiving repeated antibiotic exposure.
Evidence Supporting Probiotics for Preventing C. Diff
Who May Be at Higher Risk for C. Diff?
- Prior C. diff infection
- Multiple antibiotic exposures
- Hospitalization history
- Advanced age
- Immune suppression
- Acid suppression therapy
Probiotics are not risk-free and should be individualized for patients with severe illness, immune compromise, or complex medical conditions.
Patients often ask whether probiotics can make C. diff worse, but published studies generally evaluate probiotics as supportive rather than causative therapies.
When prevention strategies fail, additional approaches may be considered for recurrent disease.
Frequently Asked Questions
Do probiotics prevent C. diff?
Several studies suggest probiotics may reduce the risk of antibiotic-associated C. difficile infections, although optimal strains and dosing remain uncertain.
Do probiotics prevent C. diff when taking antibiotics?
Some evidence suggests probiotics may lower risk when taken during antibiotic therapy, though benefit varies depending on the patient and probiotic used.
Can probiotics make C. diff worse?
Most studies evaluate probiotics as supportive therapy, but probiotic use should be individualized, particularly in medically complex or immunocompromised patients.
Do probiotics help prevent C. diff?
Some evidence suggests probiotics may reduce the risk of antibiotic-associated C. difficile infection, although results vary among studies.
Clinical Takeaway
Do probiotics prevent C. diff? Evidence suggests they may lower risk in some patients receiving antibiotics, but decisions should remain individualized.
Managing Lyme disease often requires balancing infection control, gastrointestinal risk, and long-term outcomes rather than focusing on any single intervention alone.
Related Articles
Persistent Lyme disease mechanisms
References
- Eppes SC, Childs JA. Comparative study of cefuroxime axetil versus amoxicillin in children with early Lyme disease. Pediatrics, 109(6), 1173-1177 (2002).
- Holzbauer SM, Kemperman MM, Lynfield R. Death due to community-associated Clostridium difficile in a woman receiving prolonged antibiotic therapy for suspected lyme disease. Clin Infect Dis, 51(3), 369-370 (2010).
- Nadelman RB, Arlin Z, Wormser GP. Life-threatening complications of empiric ceftriaxone therapy for ‘seronegative Lyme disease’. South Med J, 84(10), 1263-1265 (1991).
- Lau CS, Chamberlain RS. Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. International Journal of General Medicine, 9, 27-37 (2016).
- Cammarota G, Masucci L, Ianiro G et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther, 41(9), 835-843 (2015).
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention